- Home
- PPBT vs GSIW Comparison
PPBT vs GSIW Comparison
Compare PPBT & GSIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPBT
- GSIW
- Stock Information
- Founded
- PPBT 2010
- GSIW 2016
- Country
- PPBT Israel
- GSIW Hong Kong
- Employees
- PPBT N/A
- GSIW N/A
- Industry
- PPBT Biotechnology: Pharmaceutical Preparations
- GSIW
- Sector
- PPBT Health Care
- GSIW
- Exchange
- PPBT Nasdaq
- GSIW Nasdaq
- Market Cap
- PPBT 8.7M
- GSIW 12.3M
- IPO Year
- PPBT N/A
- GSIW 2023
- Fundamental
- Price
- PPBT $3.10
- GSIW $0.47
- Analyst Decision
- PPBT Strong Buy
- GSIW
- Analyst Count
- PPBT 2
- GSIW 0
- Target Price
- PPBT $126.50
- GSIW N/A
- AVG Volume (30 Days)
- PPBT 29.0K
- GSIW 11.8M
- Earning Date
- PPBT 03-04-2025
- GSIW 12-31-2024
- Dividend Yield
- PPBT N/A
- GSIW N/A
- EPS Growth
- PPBT N/A
- GSIW N/A
- EPS
- PPBT N/A
- GSIW N/A
- Revenue
- PPBT N/A
- GSIW $1,313,795.00
- Revenue This Year
- PPBT N/A
- GSIW N/A
- Revenue Next Year
- PPBT N/A
- GSIW N/A
- P/E Ratio
- PPBT N/A
- GSIW N/A
- Revenue Growth
- PPBT N/A
- GSIW N/A
- 52 Week Low
- PPBT $2.00
- GSIW $0.43
- 52 Week High
- PPBT $20.60
- GSIW $15.00
- Technical
- Relative Strength Index (RSI)
- PPBT 41.53
- GSIW 44.06
- Support Level
- PPBT $2.90
- GSIW $0.46
- Resistance Level
- PPBT $3.20
- GSIW $0.57
- Average True Range (ATR)
- PPBT 0.21
- GSIW 0.12
- MACD
- PPBT 0.00
- GSIW -0.00
- Stochastic Oscillator
- PPBT 42.19
- GSIW 4.64
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.
About GSIW Garden Stage Limited
Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.